Advanced Drug Delivery Systems

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Advanced inorganic chemistry

Sorafenib in Advanced Hepatocellular Carcinoma

FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data.

A Description of the Advanced Research WRF Version 3

Avogadro: an advanced semantic chemical editor, visualization, and analysis platform.

Nanostructured materials for advanced energy conversion and storage devices

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

Advanced capabilities for materials modelling with Quantum ESPRESSO

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

The Advanced Theory of Statistics.

Challenges in the development of advanced Li-ion batteries: a review

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Coupling an Advanced Land Surface–Hydrology Model with the Penn State–NCAR MM5 Modeling System. Part I: Model Implementation and Sensitivity

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Pembrolizumab versus Ipilimumab in Advanced Melanoma